Schedule 13G ownership disclosure

VISTAGEN THERAPEUTICS INC

Security class unavailable · CUSIP: 92840H202

Event date: 2022-04-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
10.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-078364
Form type
SC 13G/A
Filer
Venrock Healthcare Capital Partners II, L.P.
CIK
CIK 1602264
Filed
Jul 08, 2022
Reporting period
Apr 06, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub